Severe Hemolytic Transfusion Reaction Due to Anti-D in a D plus Patient With Sickle Cell Disease

被引：16

作者：

Ipe, Tina S. ^{[1
]}

Wilkes, Jennifer J. ^{[2
]}

Hartung, Helge D. ^{[2
]}

Westhoff, Connie M. ^{[4
]}

Chou, Stella T. ^{[2
]}

Friedman, David F. ^{[2
,3
]}

机构：

[1] Houston Methodist Hosp, Dept Pathol, Houston, TX USA

[2] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA

[3] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

[4] New York Blood Ctr, Immunohematol & Genom Lab, New York, NY 10021 USA

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2015年 / 37卷 / 02期

关键词：

sickle cell disease; red blood cell transfusion; alloimmunization; delayed hemolytic transfusion reaction; RH genotype; DIRECT ANTIGLOBULIN-TEST; ALLOIMMUNIZATION; PREVALENCE;

D O I：

10.1097/MPH.0000000000000241

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A 5-year-old male with sickle cell disease presented with pain, dark urine, and fatigue 10 days after a red blood cell (RBC) transfusion. Laboratory evaluation demonstrated severe anemia, blood type O+, and anti-D in the serum. Anti-D in a D+ patient led to RH genotyping, which revealed homozygosity for RHD*DAU4 that encodes partial D antigen. Anti-D in this patient whose RBCs exclusively express partial D caused a delayed hemolytic transfusion reaction after exposure to D+ RBCs. The finding of anti-D in a D+ patient should be investigated by molecular methods to help distinguish an alloantibody from an autoantibody.

引用

页码：E135 / E137

页数：3

共 50 条

[41] A Suspected Case of Delayed Hemolytic Transfusion Reaction (DHTR) Caused by Anti-Fyb in a Patient with Sickle Cell Disease (SCD)
Mota, M. A.
Santos, L. D.
Bastos, E. P.
Almeida, L. F.
Furtado, J. M.
Rocha, F.
Aravechia, M. G.
Castilho, L.
Kutner, J. M.
TRANSFUSION, 2013, 53 : 145A - 146A
[42] Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Series
Alwaheed, Abrar J.
Alqatari, Safi G.
AlSulaiman, Amal Shehab
AlSulaiman, Reem Shehab
AMERICAN JOURNAL OF CASE REPORTS, 2022, 23
[43] Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease
Noizat-Pirenne, F.
Bachir, D.
Chadebech, P.
Michel, M.
Plonquet, A.
Lecron, J. -C.
Galacteros, F.
Bierling, P.
HAEMATOLOGICA, 2007, 92 (12) : E132 - E135
[44] Case reports: Delayed hemolytic transfusion reaction in sickle cell disease
Syed, SK
Sears, DA
Werch, JB
Udden, MM
Milam, JD
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1996, 312 (04): : 175 - 181
[45] A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease
Dessap, Armand Mekontso
Pirenne, France
Razazi, Keyvan
Moutereau, Stephane
Abid, Shariq
Brun-Buisson, Christian
Maitre, Bernard
Michel, Marc
Galacteros, Frederic
Bartolucci, Pablo
Habibi, Anoosha
AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (12) : 1181 - 1184
[46] First example of mild hemolytic disease of the newborn due to anti-D produced by a partial D phenotype DFR.
Chen, J
Moulds, M
Pumphrey, B
TRANSFUSION, 1996, 36 (09) : S112 - S112
[47] HEMOLYTIC TRANSFUSION REACTION DUE TO ANTI-A
LUNDBERG, WB
MCGINNISS, MH
TRANSFUSION, 1975, 15 (01) : 1 - 9
[48] Persistent Hemolytic Disease of the Newborn due to Breast Milk Transmission of Anti-D or Anti-JKA Alloantibodies
Leonard, Alexis
Hittson, Lauren
Darbari, Deepika
Webb, Jennifer
PEDIATRIC BLOOD & CANCER, 2017, 64 : S28 - S28
[49] RHD Genotyping for Transfusion of D plus RHD Genotype-Matched Units to D plus Patients with History of Anti-D
Chou, S.
Mewha, J.
Friedman, D.
Mlkvy, J.
Hue-Roye, K.
Vege, S.
Westhoff, C.
TRANSFUSION, 2023, 63 : 48A - 49A
[50] Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient with Sickle Cell Disease: Case Report and Review of Literature
Jasinski, Sylwia
Htun, Zeyar
Glasser, Chana
PEDIATRIC BLOOD & CANCER, 2017, 64 : S94 - S95

← 1 2 3 4 5 →